Historical record - last NADAC publication: 10/18/2023
Product Information
DEXTROAMP-AMPHETAM 12.5 MG TAB is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.5223 per EA under NDC 70010011401. Its NADAC has been published 14 times since Aug 9, 2023.
The High Outlier badge above means this manufacturer's average price in the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
DEXTROAMP-AMPHETAM 12.5 MG TAB
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine SulfateStrength
3.125; 3.125; 3.125; 3.125 mg/1; mg/1; mg/1; mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010011401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
10/18/2023
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA215771On Market Since
3/28/2023
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has been published 14 times since Aug 9, 2023, and over the history we have for it it has declined 14.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5223 per EA |
|---|---|
| All-time high | $0.6121 (Aug 16, 2023) |
| All-time low | $0.5223 (Oct 18, 2023) |
| Median price | $0.5319 |
| Average price | $0.5406 |
| Largest weekly change | -13.1% (Aug 23, 2023) |
| Weeks tracked | 14 |
| Tracking since | Aug 9, 2023 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAM 12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAM 12.5 MG TAB, manufactured by Granules Pharmaceuticals Inc., is $0.5223 per EA (NDC 70010011401), effective Nov 8, 2023.
How has the price of DEXTROAMP-AMPHETAM 12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has declined 14.7%. It has been tracked across 14 weekly CMS publications since Aug 9, 2023.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAM 12.5 MG TAB?
Since Aug 9, 2023, the NADAC for DEXTROAMP-AMPHETAM 12.5 MG TAB has ranged from a low of $0.5223 (Oct 18, 2023) to a high of $0.6121 (Aug 16, 2023), with a median of $0.5319 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAM 12.5 MG TAB?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DEXTROAMP-AMPHETAM 12.5 MG TAB, is $0.3301 per EA — about 37% below DEXTROAMP-AMPHETAM 12.5 MG TAB.
Who manufactures DEXTROAMP-AMPHETAM 12.5 MG TAB?
DEXTROAMP-AMPHETAM 12.5 MG TAB (NDC 70010011401) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification